Erythropoietin Stimulating Agents

Questions discussed in this category

Are there instances when you use erythropoietin stimulating agents in patients with acute kidney injury requiring dialysis?

2 Answers available

When do you avoid or stop erythropoietin-stimulating agents in patients with anemia and end stage kidney disease?

1 Answer available

Papers discussed in this category

BMC nephrology, 2022 Mar 13

Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial.

Related Topics